| 11/03/2020 - MEDEORA and LIMS at work to Extend Portfolio with QLIMS LIMS Platform The LIMS software from Australian software provider OnQ Software is now also available in Germany: The two partner companies MEDEORA and LIMS at work are responsible for acquiring new customers for QLIMS in Germany, Austria, and Switzerland (DACH). Their services also include implementation, training, and support.
11/03/2020 - From the Bench to Benchling Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and Michael Schwartz, Head of Product Marketing. [Read More]
11/03/2020 - Sunquest Mitogen LIMS  Sunquest Mitogen LIMS is a comprehensive and flexible molecular and genetic laboratory information management system. As COVID-19 continues to spread throughout the world, Sunquest Mitogen LIMS for COVID-19 is available to labs looking to quickly stand up testing in response to the pandemic. [LEARN MORE]
11/03/2020 - COVID-19 Insights: Streamlining lab work in these challenging times  During this pandemic, around half of labs worldwide are shut down and only 14% of labs are fully functional at a time when 100% of labs need to be thriving. Support for labs impacted by the restrictions imposed by the crisis is critical. Tools such as laboratory information management systems (LIMS) and electronic laboratory notebooks (ELNs), among other solutions, can help mitigate the impact on life in the lab. [Read More] | 
In this "short communication" from the International Journal of Infectious Diseases, Xu et al. provide a succinct review of the currently available laboratory testing technologies used to verify COVID-19 infection in patients. The authors review viral cultures, whole genome sequencing, real-time RT-PCR, isothermal amplification, and serological testing, as well as point-of-care testing utilizing one of those methods. They also discuss the sample types that should be collected, and at what stage they are most effective. They close by noting that choosing "a diagnostic assay for COVID-19 should take the characteristics and advantages of various technologies, as well as different clinical scenarios and requirements, into full consideration."
This document is based on a presentation delivered by chemist and automation consultant Joe Liscouski at the 2nd Annual Lab Asset & Facility Management in Pharma 2019 conference held in San Diego, CA, on October 22nd, 2019. It is not a verbatim transcript, but an expansion of the material presented. The presentation addressed the importance of effective technology management and planning within scientific work. With improved technology management and planning, "[t]hat work should yield better organized systems, reduced costs, better workflows, and improved ROI. How do you go about it? That is what we’ll start to address in this material."
